Increasing number of National pharmacovigilance centers across the globe. However, you will be able to benefit from a comprehensive range of products and services.
Request for a sample of this research report – https://www.gminsights.com/request-sample/detail/853
The phase IV clinical trial is not a disease, but it is not a disease.
Contract outsourcing market size what valued over $ 1 billion in 2015, poised to grow at 12.2% from 2016 to 2024 and surpass USD 4 billion by 2024. It is widely opted by companies to avoid large investments and delegates.
US pharmacovigilance market size was valued at more than USD 1 billion in 2015, with expectations to grow at 10.7% over the period, owing to favorable governmental regulations, huge clinical trial volume and presence of large scale research companies. Additionally, growing patient concerns.
United States pharmacovigilance market value what valued over USD 230 million in 2015 and should be 10.2% CAGR from 2016 to 2024, to surpass USD 550 million by 2024. Rising demand for new drug development, growing geriatric population and increasing by pharmaceutical companies should be regional Industry growth. India pharmacovigilance market growth is more than 14% from 2016 to 2024, and expected to reach USD 668 million by 2024. The strong and robust growth is attributed to the increasing number of clinical trials Countries
Key industry players are looking for Quintiles offer literature monitoring, safety aggregate reporting, benefit risk management, analytics and signal detection services. Synowledge offer signal detection services, which help to diagnose and diagnose hi-tech visualization techniques.
Many industry participants are focusing on pharmacovigilance services as a feasible cost reduction avenue. Outsourcing helps achieve better pharmacovigilance through regulatory compliance, better quality, enhanced productivity and improved strategic outcomes.
Pharmaceutical Market Size By Clinical Trial Phase (Preclinical, Phase I, Phase II, Phase III, Phase IV), By Service Provider (Intr ,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Store Category: Industry Analysis Report ), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024 „in detail along with the table of contents:
Https://www.gminsights.com/industry-analysis/pharmacovigilance-market
Key insights from the report include:
Europe pharmacovigilance market size was over USD 790 million in 2015 CAGR. United Kingdom, United Kingdom, United Kingdom.
Brazil pharmacovigilance market share what more than 60% of regional revenue for 2015, with target slated to exceed USD 300 million by 2024.
Phase III clinical trial market size was more than USD 450 million in 2015, with expectations to grow over 10% CAGR,
Contract outsourcing held more than 50% of pharmacovigilance market share with target market size of over USD 1.7 billion in 2015.
Global pharmacovigilance market (CROs). The key industry participants include Accenture, Quintiles, Cognance Technology Solutions, Boehringer Ingelheim, Covance, PAREXEL International Corporation, Bristol-Myers Squibb, Janssen Research & Development, Synowlwedge, United BioSource Corporation and ICON.
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, US, is a global market research and consulting service provider; Offering syndicated and custom research reports. Our business intelligence and industry research reports provide clients with penetrative insights and actionable market data. These exhaustive reports are designed using a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.